Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy

Journal of Applied Physiology

Volumn 108, Issue 1, 2010, Pages 105-111

  Blaauw, Bert ^a,b   Agatea, Lisa ^b   Toniolo, Luana ^a   Canato, Marta ^a   Quarta, Marco ^a   Dyar, Kenneth A ^b   Danieli Betto, Daniela ^a   Betto, Romeo ^c   Schiaffino, Stefano ^b,c   Reggiani, Carlo ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c CNR   (Italy)

Author keywords

sarcoglycan null; Collagen 6a1 null; mdx; Skinned muscle fibers

Indexed keywords

ALPHA SARCOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECCENTRIC MUSCLE CONTRACTION; FEMALE; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOFIBRILLAR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES;

EID: 73949151227     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00803.2009     Document Type: Article

References (34)

1. Allen DG. Eccentric muscle damage: mechanisms of early reduction of force. Acta Physiol Scand 171: 311-319, 2001.
2. Balnave CD, Allen DG. Intracellular calcium and force in single mouse muscle fibres following repeated contractions with stretch. J Physiol 488: 25-36, 1995.
3. Blaauw B, Mammucari C, Toniolo L, Agatea L, Abraham R, Sandri M, Reggiani C, Schiaffino S. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. Hum Mol Genet 17: 3686-3696, 2008.
4. Childers MK, Okamura CS, Bogan DJ, Bogan JR, Petroski GF, McDonald K, Kornegay JN. Eccentric contraction injury in dystrophic canine muscle. Arch Phys Med Rehabil 83: 1572-1578, 2002.
5. Consolino CM, Brooks SV. Susceptibility to sarcomere injury induced by single stretches of maximally activated muscles of mdx mice. J Appl Physiol 96: 633-638, 2004.
6. Consolino CM, Duclos F, Lee J, Williamson RA, Campbell KP, Brooks SV. Muscles of mice deficient in α-sarcoglycan maintain large masses and near control force values throughout the life span. Physiol Genomics 22: 244-256, 2005.
7. Coulton GR, Curtin NA, Morgan JE, Partridge TA. The mdx mouse skeletal muscle myopathy. II. Contractile properties. Neuropathol Appl Neurobiol 14: 299-314, 1988.
8. Deconinck N, Ragot T, Marechal G, Perricaudet M, Gillis JM. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 93: 3570-3574, 1996.
9. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471, 1998.
10. Edman KA. Contractile properties of mouse single muscle fibers, a comparison with amphibian muscle fibers. J Exp Biol 208: 1905-1913, 2005.
11. Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I. Phenotypic correction of α-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector. Mol Ther 15: 53-61, 2007.
12. Goulding D, Bullard B, Gautel M. A survey of in situ sarcomere extension in mouse skeletal muscle. J Muscle Res Cell Motil 18: 465-472, 1997.
13. Gruner JA, Altman J, Spivack N. Effects of arrested cerebellar development on locomotion in the rat. Cinematographic and electromyographic analysis. Exp Brain Res 40: 361-373, 1980.
14. Hack AA, Cordier L, Shoturma DI, Lam MY, Sweeney HL, McNally EM. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA 96: 10723-10728, 1999.
15. Hasselgren PO, Wray C, Mammen J. Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 290: 1-10, 2002.
16. 2-deficient dystrophic mouse are not vulnerable to eccentric contractions. Exp Physiol 89: 531-539, 2004.
17. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta P, Columbaro M, Volpin D, Bressan GM, Bernardi P, Bonaldo P. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 35: 367-371, 2003.
18. Lynch GS, Rafael JA, Chamberlain JS, Faulkner JA. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am J Physiol Cell Physiol 279: C1290-C1294, 2000.
19. McArdle A, Edwards RH, Jackson MJ. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin Sci (Lond) 80: 367-371, 1991.
20. Moens P, Baatsen PH, Marechal G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14: 446-451, 1993.
21. Morgan DL. New insights into the behavior of muscle during active lengthening. Biophys J 57: 209-221, 1990.
22. Murphy RM, Goodman CA, McKenna MJ, Bennie J, Leikis M, Lamb GD. Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise. J Appl Physiol 103: 926-931, 2007.
23. Pellegrino MA, Canepari M, Rossi R, D'Antona G, Reggiani C, Bottinelli R. Orthologous myosin isoforms and scaling of shortening velocity with body size in mouse, rat, rabbit and human muscles. J Physiol 546: 677-689, 2003.
24. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
25. Proske U, Morgan DL. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 537: 333-345, 2001.
26. Sacco P, Jones DA, Dick JR, Vrbova G. Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci (Lond) 82: 227-236, 1992.
27. Schertzer JD, Ryall JG, Lynch GS. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Am J Physiol Endocrinol Metab 291: E499-E505, 2006.
28. Stephenson DG, Williams DA. Effects of sarcomere length on the force-pCa relation in fast- and slow-twitch skinned muscle fibres from the rat. J Physiol 333: 637-653, 1982.
29. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 53 Suppl 1: S12-S18, 2004.
30. Toniolo L, Maccatrozzo L, Patruno M, Pavan E, Caliaro F, Rossi R, Rinaldi C, Canepari M, Reggiani C, Mascarello F. Fiber types in canine muscles: myosin isoform expression and functional characterization. Am J Physiol Cell Physiol 292: C1915-C1926, 2007.
31. Warren GL, Lowe DA, Hayes DA, Karwoski CJ, Prior BM, Armstrong RB. Excitation failure in eccentric contraction-induced injury of mouse soleus muscle. J Physiol 468: 487-499, 1993.
32. Whitehead NP, Pham C, Gervasio OL, Allen DG. N-acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 586: 2003-2014, 2008.
33. i and muscle damage in the mdx mouse. J Physiol 562: 367-380, 2005.
34. Yu JG, Carlsson L, Thornell LE. Evidence for myofibril remodeling as opposed to myofibril damage in human muscles with DOMS: an ultrastructural and immunoelectron microscopic study. Histochem Cell Biol 121: 219-227, 2004.